[1]
wawang anwarudin, “Cost-Effectiveness Analysis of Rifampicin and Bedaquiline Use for Tuberculosis Treatment: A Systematic Review”, JHEPR, vol. 4, no. 1, pp. 95–103, Apr. 2026.